Evidence map›Paper›PMID 30050443›Full record

ArticleFrontiers in pharmacology2018

Bioactive Phenolics of the Genus

Daniil N Olennikov, Nadezhda K Chirikova, Nina I Kashchenko, Vyacheslav M Nikolaev, Sang-Woo Kim, Cecile Vennos

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 118 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. KoreanFrontiers in pharmacology · 2026
    Review
  6. Effects of ThreeThe journal of poultry science · 2026
    Article
  7. Article
  8. Article
  9. Chemodiversity of Arctic PlantPlants (Basel, Switzerland) · 2024
    Article
  10. Artemvulactone E isolated fromFrontiers in pharmacology · 2024
    Article
  11. Antiobesity Drug Discovery Research:Current drug targets · 2024
    Review
  12. Article
  13. Article
  14. Metabolites ofMetabolites · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Daniil N OlennikovLaboratory of Medical and Biological Research, Institute of General and Experimental Biology, Siberian Division, Russian Academy of Science, Ulan-Ude, Russia.
Nadezhda K ChirikovaDepartment of Biochemistry and Biotechnology, North-Eastern Federal University, Yakutsk, Russia.
Nina I KashchenkoLaboratory of Medical and Biological Research, Institute of General and Experimental Biology, Siberian Division, Russian Academy of Science, Ulan-Ude, Russia.
Vyacheslav M NikolaevDepartment of Studying the Mechanisms of Adaptation, Scientific Center of Complex Medical Sciences, Yakutsk, Russia.
Sang-Woo KimDepartment of Biological Sciences, Pusan National University, Busan, South Korea.
Cecile VennosRegulatory and Medical Scientific Affairs, Padma AG, Hinwil, Switzerland.
Institute of General and Experimental Biology · RUNorth-Eastern Federal University · RUPusan National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ArtemisiaAsteraceaecaffeoylquinic acidsflavonoidshigh performance liquid chromatographymass spectrometryα-amylase inhibitionα-glucosidase inhibition

Identifiers

PMID30050443
PMCPMC6052120
OpenAlexW2875881146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.